As expected, the vast majority (103/120, 85.8%) of MYCN amplified High-MKI neuroblastomas overly expressed MYCN protein, including 2 tumors also having simultaneous MYCN and MYC protein expression. This evidence concerns the gene MYCN and neuroblastoma.